Skip to main content

Compugen Ltd

CGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001119774

In the last 90 days, Compugen Ltd insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; ARK Invest is the only superinvestor holding it.

Q1 2023 vs. Q4 2022

How the institutions holding Compugen Ltd changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of CGEN: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders7468−6
Shares16.2M10.9M−5.26M (−32.5%)
Value$11.6M$7.68M−$3.91M (−33.7%)

New holders (6)

Institutions that held Compugen Ltd at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to CGEN in Q1 2023
InstitutionSharesValue% of portfolio
Susquehanna International Group Ltd.80,066$56.2K0.03%
Vident Investment Advisory, LLC29,688$20.8K0.00%
Two Sigma Securities, LLC22,297$15.7K0.00%
Virtu Financial LLC21,484$15.0K0.00%
Ewa, LLC17,049$12.6K0.01%
Private Advisor Group, LLC10,111$7.10K0.00%

Sold out (12)

Institutions that held Compugen Ltd at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of CGEN in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
ARK Investment Management LLCSuperinvestorARK Invest2,410,414$1.73M
Citadel Advisors LLC215,367$154.1K
Man Group plc93,106$66.6K
Ergoteles LLC57,181$40.9K
Crestwood Advisors Group LLC15,720$11.3K
Engineers Gate Manager LP14,523$10.4K
Group One Trading, L.P.8,102$5.80K
Macroview Investment Management LLC1,395$998
Focused Wealth Management, Inc1,200$859
Ronald Blue Trust, Inc.139$0
IFP Advisors, Inc50–
CWS Financial Advisors, LLC10,000–